Delivery Order SPE2DB24D8002-SPE2DB25FJMQJ
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $2,252.99 and a performance period through December 18, 2023. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
This is a $8,471.66 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has an ultimate completion date of January 24, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $14,529.07 firm fixed-price contract is for the delivery of Eliquis 5 mg tablets to support U.S. military medical operations. The contract is not set-aside and has an ultimate completion date of April 27, 2023. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The contract, valued at $10,949.56, has a firm fixed price and an ultimate completion date of December 4, 2024. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which is an Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,413.34, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 13, 2025. Dakota Drug, Inc. also holds a larger indefinite delivery contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $8,304.36, is for the delivery of Eliquis 5 mg tablets. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,230.88, is for the delivery of 4562802555 ELIQUIS 5 MG TABLET 60S to support military medical operations. Dakota Drug, Inc. holds a large Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,733.06, is for the delivery of Eliquis 5 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to provide a comprehensive...
This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of Eliquis 2.5 mg tablets, a prescription medication. The contract has a ceiling value of $1,341.90 and a performance period through August 6, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $5,560.45 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...